HETEROLOGOUS FUSION PROTEINS COMPRISING A GLP-1 COMPOUND FUSED TO ANOTHER POLYPEPTIDE, PHARMACEUTICAL FORMULATIONS COMPRISING THEM AND USE THEREOF IN THE PREPARATION OF MEDICAMENTS

摘要

The present invention relates to glucagon-like-1 compounds fused to proteins that have the effect of extending the in vivo half-life of the peptides. These fusion proteins can be used to treat non-insulin dependent diabetes mellitus as well as a variety of other conditions.